Answers are grounded in this paper and cite their sources.
Modeling examines how β-sheet breaker peptides disrupt protein aggregates in neurological disorders, suggesting therapeutic potential.
β-Sheet–breaker peptides can destabilize protein aggregates associated with neurological disorders, thereby interfering with fibril formation. Given the pivotal role of misfolded protein oligomers such as amyloid-β and α-synuclein in Alzheimer’s...
No takes yet. Share an insight, caveat, or question.
Gulsah Gul (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: